Sol Gel Technologies Stock In The News

SLGL Stock  USD 11.00  0.11  0.99%   
Our overall analysis of Sol Gel's news coverage and content from conventional and social sources shows investors' bearish mood towards Sol Gel Technologies. The specific impact of Sol Gel news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Sol Gel's overall financial health and prospects. It also depends on the type and quality of a news publisher. Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Sol Gel headlines in addition to utilizing other, more conventional financial analysis modules. Check out Sol Gel Backtesting and Sol Gel Hype Analysis.

Sol Gel Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Sol-Gel Reports First Quarter 2025 Results
https://www.globenewswire.com/news-release/2025/05/23/3087406/0/en/Sol-Gel-Reports-First-Quarter-2025-Results.html
 Neutral
Macroaxis News: globenewswire.com
Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.
https://www.globenewswire.com/news-release/2025/04/17/3063410/0/en/Sol-Gel-and-Mayne-Pharma-Announce-the-Purchase-of-EPSOLAY-and-TWYNEO-in-the-U-S.html
 Bullish
Macroaxis News: globenewswire.com
Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study
https://www.globenewswire.com/news-release/2023/11/30/2788454/0/en/Sol-Gel-Technologies-Screens-First-Patient-for-SGT-610-Phase-3-Study.html
 Neutral
Macroaxis News: globenewswire.com
Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610
https://www.globenewswire.com/news-release/2023/11/28/2786910/0/en/Sol-Gel-Technologies-Ltd-to-Host-Virtual-KOL-Event-on-Gorlin-Syndrome-and-the-Upcoming-Phase-3-Trial-for-SGT-610.html
 Neutral
Macroaxis News: globenewswire.com
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update
https://www.globenewswire.com/news-release/2023/11/09/2777169/0/en/Sol-Gel-Technologies-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
 Neutral
Macroaxis News: globenewswire.com
Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
https://www.globenewswire.com/news-release/2023/08/30/2734272/0/en/Sol-Gel-Technologies-to-Participate-in-the-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html
 Bullish
Macroaxis News: globenewswire.com
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update
https://www.globenewswire.com/news-release/2023/08/10/2722500/0/en/Sol-Gel-Technologies-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
 Bullish
Yahoo News
Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL...
https://finance.yahoo.com/news/sol-gel-technologies-ltd-nasdaq-100436211.html
 Bullish
Yahoo News
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada
https://finance.yahoo.com/news/sol-gel-searchlight-pharma-announce-113000994.html
 Bullish
Macroaxis News: globenewswire.com
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada
https://www.globenewswire.com/news-release/2023/06/06/2682638/0/en/Sol-Gel-and-Searchlight-Pharma-Announce-Licensing-Agreements-to-Commercialize-TWYNEO-and-EPSOLAY-in-Canada.html
 Bullish

Sol Gel Technologies Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Sol and other traded companies coverage with news coverage. We help investors stay connected with Sol headlines for the 28th of July to make an informed investment decision based on correlating the impacts of news items on Sol Stock performance. Please note that trading solely based on the Sol Gel Technologies hype is not for everyone as timely availability and quick action are needed to avoid losses.
Sol Gel's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Sol Gel Technologies investors visualize upcoming and past events in order to time the market based on Sol Gel Technologies noise-free hype analysis.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sol Gel in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sol Gel's short interest history, or implied volatility extrapolated from Sol Gel options trading.
When determining whether Sol Gel Technologies is a strong investment it is important to analyze Sol Gel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sol Gel's future performance. For an informed investment choice regarding Sol Stock, refer to the following important reports:
Check out Sol Gel Backtesting and Sol Gel Hype Analysis.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sol Gel. If investors know Sol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sol Gel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.70)
Revenue Per Share
4.345
Quarterly Revenue Growth
1.212
Return On Assets
(0.27)
Return On Equity
(0.49)
The market value of Sol Gel Technologies is measured differently than its book value, which is the value of Sol that is recorded on the company's balance sheet. Investors also form their own opinion of Sol Gel's value that differs from its market value or its book value, called intrinsic value, which is Sol Gel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sol Gel's market value can be influenced by many factors that don't directly affect Sol Gel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sol Gel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sol Gel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sol Gel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.